NCT03406429 - rTMS as a Treatment for PPA | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions

Logopenic Variant Primary Progressive AphasiaNon-Fluent Primary Progressive Aphasia

Interventions

DEVICE

Active rTMS

All study participants will receive one block of active rTMS. Each block will consist of daily sessions of 20Hz active rTMS delivered to the left dorsolateral prefrontal cortex (dlPFC) over five days (Monday through Friday).

DEVICE

SHAM rTMS

All study participants will receive one block of SHAM rTMS. Each block will consist of daily sessions of 20Hz SHAM rTMS delivered to the left dorsolateral prefrontal cortex (dlPFC) over five days (Monday through Friday).

Trial Locations (1)

02129

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER